The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFocusrite Regulatory News (TUNE)

Share Price Information for Focusrite (TUNE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 380.00
Bid: 370.00
Ask: 390.00
Change: 0.00 (0.00%)
Spread: 20.00 (5.405%)
Open: 380.00
High: 380.00
Low: 380.00
Prev. Close: 380.00
TUNE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notification of PDMR Transactions

19 Mar 2024 16:44

RNS Number : 4804H
Focusrite PLC
19 March 2024
 

For immediate release

Focusrite plc

("Focusrite" or "the Group")

Focusrite announces that on 19 March 2024 Sally McKone, Chief Financial Officer and executive director, has purchased 6,900 ordinary shares of 0.1p each in Focusrite ("Ordinary Shares") on market at prices between 286.800p and 297.400p per Ordinary Share. Following this share purchase, Sally McKone will hold 34,530 Ordinary Shares in Focusrite representing 0.058% of the total number of shares in the Company.

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

1

Details of the persons discharging managerial responsibilities person closely associated

a)

Name

Sally McKone

 

2

Reason for the notification

a)

Position/status

 Chief Financial Officer

b)

Initial notification /Amendment

 Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Focusrite plc

b)

Legal Entity Identifier

213800JJ51KA4LOTF736

4

Details of the transaction(s): section to be repeated for (i) each type ofinstrument; (ii) each type of transaction; (iii) each date; and (iv) each placewhere transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of 0.1p each in Focusrite plc

Identification code

GB00BSBMW716

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

 

Prices per share

Volumes Acquired

297.400p

200

286.800p

2900

289.000p

3800

d)

Aggregated information

- Aggregated volume 

- Price 

Aggregated information

6900

£19,926.50 

e)

Date of the transaction

19 March 2024

f)

Place of the transaction

London Stock Exchange's AIM Market

 

- ends -

 

Enquiries:

Focusrite plc

+44 (0) 1494 462246

Tim Carroll (CEO) / Sally McKone (CFO)

 

Investec Bank plc (Nominated Adviser and Joint Broker)

+44 (0) 20 7597 5970

David Flin / Edward Knight / William Brinkley

 

Peel Hunt LLP (Joint Broker)

+44 (0) 20 7418 8900

Paul Gillam / Adam Telling

 

Belvedere Communications (Financial PR)

 +44 20 7653 8702

John West / Llewellyn Angus / Lily Pearce

 

 

 

 

 

Notes to Editors

Focusrite plc is a global audio products group that develops and markets proprietary hardware and software products. Used by audio professionals and musicians, its solutions facilitate the high-quality production of recorded and live sound. The Focusrite Group trades under thirteen established brands: Focusrite, Focusrite Pro, Novation, Ampify, ADAM Audio, Martin Audio, Optimal Audio, Linea Research Sequential, Oberheim, Sonnox, OutBoard and TiMax.

With a high-quality reputation and a rich heritage spanning decades, its brands are category leaders in the music-making and audio recording industries. Focusrite and Focusrite Pro offer audio interfaces and other products for recording musicians, producers and professional audio facilities. Novation and Ampify products are used in the creation of electronic music, from synthesizers and grooveboxes to industry-shaping controllers and inspirational music-making apps. ADAM Audio studio monitors have earned a worldwide reputation based on technological innovation in the field of studio loudspeaker technology. Martin Audio designs and manufactures performance-ready systems across the spectrum of sound reinforcement applications. Linea designs, develops, manufactures and sells market innovative professional audio equipment globally. Sequential designs and manufactures high end analogue synthesizers under the Sequential and Oberheim brands. Sonnox is a leading designer of innovative, high-quality, award-winning audio processing software plug-ins for professional audio engineers. TiMax specialises in innovative immersive audio and show control technologies. OutBoard manufactures and sells industry standard rigging control products for live events, together with enterprise-level safety test, preparation and quality management for global rental companies and venues.

The Company has offices in four continents and a global customer base with a distribution network covering approximately 240 territories.

Focusrite plc is traded on the AIM market, London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBLGDXBSBDGSC
Date   Source Headline
25th Mar 20194:44 pmRNSGrant of Share Options to PDMR
19th Mar 20194:42 pmRNSTR-1
19th Mar 20197:00 amRNSTrading Update
11th Mar 20198:36 amRNSTR-1
28th Feb 20196:15 pmRNSTR-1
8th Feb 20197:00 amRNSNotification of transaction by PDMR
7th Feb 201910:32 amRNSHolding(s) in Company
6th Feb 20191:38 pmRNSHolding(s) in Company
28th Jan 20199:36 amRNSHolding(s) in Company
24th Jan 20192:57 pmRNSCompletion of Secondary Placing of Shares
24th Jan 20197:00 amRNSProposed Secondary Placing of Shares
21st Dec 201812:20 pmRNSResult of 2018 Annual General Meeting
21st Dec 20187:00 amRNSAGM Statement and Update on Trading
14th Dec 201810:14 amRNSDirectors' Dealings
4th Dec 20187:00 amRNSExercise of Share Options
3rd Dec 20183:12 pmRNSExercise of Share Options by a PDMR
26th Nov 20183:36 pmRNSGrant of Share Options to Directors
23rd Nov 201812:34 pmRNSDirector/PDMR Shareholding
23rd Nov 201812:29 pmRNSDirector/PDMR Shareholding
20th Nov 20187:00 amRNSFinal Results for the Year Ended 31 August 2018
8th Nov 20184:12 pmRNSHolding(s) in Company
18th Sep 20187:00 amRNSTrading Update
27th Jul 20189:45 amRNSTR-1
3rd Jul 201810:53 amRNSTR-1
29th May 20187:00 amRNSAppointment of Non-executive director
18th May 20185:06 pmRNSHolding(s) in Company
8th May 20189:31 amRNSDirector/PDMR Shareholding
3rd May 201812:18 pmRNSHolding(s) in Company
24th Apr 20187:00 amRNSHalf Year Results
9th Mar 20183:45 pmRNSDirector/PDMR Shareholding
9th Mar 20187:00 amRNSTrading Update
29th Jan 20183:38 pmRNSTR-1
29th Jan 201811:27 amRNSDirector/PDMR Shareholding
18th Jan 20187:00 amRNSDirector/PDMR Shareholding
10th Jan 20183:02 pmRNSResult of 2018 AGM
10th Jan 20187:00 amRNSAGM Statement and Update on Trading
19th Dec 20177:00 amRNSDirector/PDMR Shareholding
19th Dec 20177:00 amRNSDirector/PDMR Shareholding
15th Dec 20174:02 pmRNSDirector's Dealings
14th Dec 20179:56 amRNSDirector/PDMR Shareholding
5th Dec 201712:56 pmRNSTR-1: Standard form
30th Nov 20176:14 pmRNSCompletion of Secondary Placing of Shares
30th Nov 20174:35 pmRNSProposed Secondary Placing of Shares
24th Nov 20174:24 pmRNSPDMR Shareholding
23rd Nov 201710:22 amRNSPDMR Grant of Share Options
23rd Nov 201710:21 amRNSDirector's Dealings
23rd Nov 20177:00 amRNSDirector Share Dealings - Replacement
22nd Nov 20172:50 pmRNSDirector Share Dealings
21st Nov 20177:00 amRNSFinal Results for the Year Ended 31 August 2017
20th Sep 20172:54 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.